-
- 抗原 See all ITGA2 抗体
- ITGA2 (Integrin alpha 2 (ITGA2))
-
适用
- 小鼠
-
宿主
- 大鼠
-
克隆类型
- 单克隆
-
标记
- This ITGA2 antibody is un-conjugated
-
应用范围
- Flow Cytometry (FACS)
- 产品特性
- Purified IgM
- 纯化方法
- Purified
- 克隆位点
- DX5
- 亚型
- IgM
- Top Product
- Discover our top product ITGA2 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5 mg/mL
-
-
Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity." in: Cancer letters, Vol. 272, Issue 2, pp. 285-95, (2008) (PubMed).
: "
-
Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity." in: Cancer letters, Vol. 272, Issue 2, pp. 285-95, (2008) (PubMed).
-
- 抗原
- ITGA2 (Integrin alpha 2 (ITGA2))
- 别名
- CD49b (ITGA2 产品)
- 背景
- Synonyms: INTEGRIN ALPHA 2 CHAIN, VLA-2
- 基因ID
- 16398
- UniProt
- Q62469
- 途径
- CXCR4-mediated Signaling Events, Smooth Muscle Cell Migration, Integrin Complex
-